SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-130422
Filing Date
2023-05-01
Accepted
2023-05-01 16:11:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d460913ddefa14a.htm DEFA14A 10795
2 GRAPHIC g460913g52g98.jpg GRAPHIC 256777
3 GRAPHIC g460913g82t31.jpg GRAPHIC 430577
  Complete submission text file 0001193125-23-130422.txt   958760
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35890 | Film No.: 23873747
SIC: 2834 Pharmaceutical Preparations